UNSPSC 85603123: Supplement left large intestine with nonautologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left large intestine with nonautologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0DUG4KZ

UNSPSC 85603123 Supplement left large intestine with nonautologous tissue substitute, percutaneous endoscopic approach is a Commodity code that shows little relevant recent activity under state and local procurement. The code nominally describes a specific surgical procedure — implantation of synthetic tissue into the colon using endoscopic technique — yet the recent opportunities tagged to this code involve medical administration, occupational surveillance, pharmacy management, and temporary clinical staffing, none of which align with surgical supply or procedural implant procurement. The mismatch suggests either miscoding in the source records or that state and local procurement offices are not currently buying implantable tissue substitutes or related surgical consumables under this taxonomy designation.

The six opportunities posted between July and September 2026 span issuing bodies including a city retirement office (Phoenix), municipal employer (Long Beach), state transportation agency (Washington), county juvenile justice department (Harris County), county health consortium (Collier County), and regional health system (Santa Clara County). Geographic spread covers Arizona, California, Florida, Texas, and Washington. Representative recent solicitations include the Phoenix Retirement Office's RFP for independent medical evaluation services (response due October 16, 2026) and the Washington State Department of Transportation's RFP for occupational medical surveillance across 14 ferry system locations (response due October 9, 2026). No procurement activity under this code reflects actual surgical implant supply, procedure kits, or tissue bank services.